Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 256 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2412 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2023-12-07 | 2024-01-11 | 212717 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2023-12-07 | 2024-04-18 | 212725 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-12-07 | 2024-03-21 | 212730 |
| TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2023-12-14 | 2024-02-15 | 213365 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-12-14 | 2024-02-01 | 213371 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-12-14 | 2024-03-21 | 213374 |
| TEVA-METOPROLOL | 100MG | TABLET | Resolved | 2024-01-11 | 2024-04-18 | 215701 |
| REVIA | 50MG | TABLET | Resolved | 2024-01-11 | 2024-02-13 | 215710 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2024-01-11 | 2024-03-18 | 215713 |
| TEVA-SERTRALINE | 100MG | CAPSULE | Resolved | 2024-01-11 | 2024-02-01 | 215716 |
| TEVA-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2024-01-11 | 2024-03-18 | 215719 |
| ACT QUETIAPINE | 200MG | TABLET | Resolved | 2024-01-11 | 2024-04-11 | 215725 |
| TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2024-01-11 | 2024-04-25 | 215728 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2024-01-11 | 2024-02-01 | 215731 |
| TEVA-DILTIAZEM XC | 240MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-05-09 | 215740 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-02-22 | 215743 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-02-22 | 215746 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 2.5MG 8MG | TABLET | Resolved | 2024-01-11 | 2024-01-19 | 215757 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2024-01-18 | 2024-03-07 | 216457 |
| TEVA-DILTIAZEM XC | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-18 | 2024-05-09 | 216466 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |